AVMA news
FDA approves generic drugs for use in cats, dogs, horses, ferrets
The Food and Drug Administration announced in January that the agency had approved new generic drugs for cats, dogs, and horses and granted a…
AVMA news
New listings in AVMA Animal Health Studies Database – March 2023
Among the new listings in the AVMA Animal Health Studies Database is a pilot study of a novel therapeutic probiotic in dogs with diarrhea and…
AVMA news
AVMA members press Congress for illicit xylazine, dog importation laws
Nearly 120 veterinarians and veterinary students attended the 2023 AVMA annual legislative fly-in, held April 17-19 in Washington, D.C. They urged…
AVMA news
New listings in AVMA Animal Health Studies Database – May 2023
The latest list of veterinary clinical studies in the AVMA Animal Health Studies Database (AAHSD) are available, including a study evaluating the…
AVMA news
Canine parvovirus treatment receives conditional approval
The U.S. Department of Agriculture has granted a conditional license for the Canine Parvovirus Monoclonal Antibody—Elanco's first monoclonal antibody…
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
AVMA news
AVMA leaders to discuss environmental sustainability, spectrum of care
Meeting this July in Denver, the AVMA House of Delegates (HOD) will consider new and revised policy proposals dealing with wolf hybrids, tail docking,…
AVMA news
Four veterinary scientists recognized with AVMA research awards
The AVMA honored Drs. Jim E. Riviere, Nicholas (Nick) Jeffery, Natasha Olby, and Boaz Arzi with 2023 AVMA Excellence Awards for contributions to…
AVMA news
Drugs treating epilepsy, feline diabetes receive FDA approval
The Food and Drug Administration (FDA) has recently approved a number of animal drugs, including those that treat idiopathic epilepsy in dogs and…
AVMA news
Shortage of cancer drugs having devastating effects on patients, veterinarians
Chemotherapy drugs, including cisplatin and carboplatin, have been in short supply for months. The situation is affecting animal patients and…
AVMA news
FDA releases updated plan for antimicrobial stewardship in veterinary settings
The U.S. Food and Drug Administration’s Center for Veterinary Medicine on October 1 launched the latest phases of its ongoing plan to promote…
AVMA news
AAHA publishes allergic skin disease guidelines for dogs, cats
On October 31, the American Animal Hospital Association (AAHA) announced the publication of the 2023 AAHA Management of Allergic Skin Diseases in Dogs…
AVMA news
Monoclonal antibodies show promise as new therapy for veterinary patients
More than 100 monoclonal antibodies (mAb) designed to bind to specific target proteins are available for humans, including those intended to treat…
AVMA news
North Carolina law will require veterinarians to report gabapentin use
As part of Governor Roy Cooper’s North Carolina Opioid Action Plan, a new law will require the state’s veterinarians to report the use of gabapentin…
AVMA news
New listings in AVMA Animal Health Studies Database – December 2023
New listings are posted in the AVMA Animal Health Studies Database, including a study evaluating a monoclonal antibody treatment in combination with…
blog
Year in review: 2023’s most-read blog posts
The blog topics that most drew interest from veterinary professionals this year included canine respiratory disease, mentorship, xylazine, and much…